99
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Binary and Ternary Metal Complexes Derived from Cu Acetate with Some Sulfur-Containing Chemotherapeutic Agents

&
Pages 2786-2798 | Received 08 Jul 2008, Accepted 27 Oct 2008, Published online: 03 Nov 2009
 

Abstract

Two ternary complexes, [Cu2(Pir)(Pen)(OH)(Ac)H2O] and [Cu(Pir)(Cap)(Ac)] ½H2O (where, Pen = D-penicillamine, Cap = captopril, and Pir = piroxicam) have been synthesized and characterized using elemental analyses, spectroscopic analyses (IR, UV-vis, MS), thermal analyses (TGA), conductance measurements, and magnetic measurements. The binary complexes, [Cu2(Pen)(OH)2(H2O)2] 4H2O and [Cu(Cap)Ac] 3/2H2O, have also been prepared and characterized by these techniques to facilitate the interpretation of the mixed ligand complexes. The results show that D-penicillamine can coordinate two copper atoms through amino nitrogen, and thiol sulfur after displacement of a hydrogen atom. At the same time, the ligand coordinates to the second copper atom through a carboxyl group after displacement of a hydrogen from the latter group. Captopril coordinates through thiol sulfur and carbonyl oxygen. Piroxicam coordinates as a neutral bidentate ligand in the keto form through carbonyl oxygen and pyridyl nitrogen. The magnetic moment measurements of complexes containing captopril indicate the reduction of Cu(II) to Cu(I) by the thiol group.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.